HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christian W Keller Selected Research

Peripheral Nerve Injuries

1/2016Terminal complement activation is increased and associated with disease severity in CIDP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christian W Keller Research Topics

Disease

5Multiple Sclerosis
11/2021 - 02/2016
5Inflammation (Inflammations)
01/2018 - 02/2011
4Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
11/2021 - 02/2016
4Neoplasms (Cancer)
01/2020 - 01/2017
3Autoimmune Diseases (Autoimmune Disease)
05/2021 - 11/2015
3Neuroinflammatory Diseases
01/2021 - 02/2016
2Relapsing-Remitting Multiple Sclerosis
01/2020 - 12/2019
2Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
01/2019 - 01/2016
2Polyneuropathies (Polyneuropathy)
01/2019 - 11/2015
2Myositis (Idiopathic Inflammatory Myopathies)
01/2017 - 02/2011
1Demyelinating Diseases (Demyelinating Disease)
12/2021
1Myasthenia Gravis
05/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021
1Primary angiitis of the central nervous system
01/2021
1Central Nervous System Vasculitis
01/2021
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2021
1Chronic Progressive Multiple Sclerosis
01/2020
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2020
1Lymphoma (Lymphomas)
12/2019
1Disease Progression
01/2019
1Infections
06/2017
1Communicable Diseases (Infectious Diseases)
06/2017
1Peripheral Nerve Injuries
01/2016
1Rhabdomyosarcoma
02/2013
1Inclusion Body Myositis
02/2011
1Muscular Diseases (Myopathy)
02/2011

Drug/Important Bio-Agent (IBA)

4AntigensIBA
11/2021 - 06/2017
4AntibodiesIBA
05/2021 - 01/2017
4Immunoglobulin G (IgG)IBA
05/2021 - 11/2015
4Complement System Proteins (Complement)IBA
01/2021 - 01/2016
3Myelin-Oligodendrocyte GlycoproteinIBA
12/2021 - 01/2021
3Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2017
3Intravenous Immunoglobulins (IVIG)FDA Link
01/2019 - 02/2016
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
11/2021 - 01/2021
2Histocompatibility Antigens Class IIIBA
01/2021 - 02/2011
2Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2019
2Complement Membrane Attack Complex (Membrane Attack Complex)IBA
01/2019 - 01/2016
1Cholinergic ReceptorsIBA
05/2021
1Fc Receptors (Fc Receptor)IBA
05/2021
1cytochrome b245IBA
01/2021
1Fibrinogen (Factor I)FDA Link
01/2021
1InterferonsIBA
01/2021
1InterleukinsIBA
01/2021
1chenodeoxycholate sulfate conjugate (CDCS)IBA
01/2021
1NADP (NADPH)IBA
01/2021
1OvalbuminIBA
01/2021
1Peptides (Polypeptides)IBA
01/2021
1PhosphatidylserinesIBA
01/2021
1IntegrinsIBA
01/2021
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2021
1Complement Factor H (Factor H)IBA
01/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021
1Leukocyte Common Antigens (CD45 Antigen)IBA
01/2021
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2021
1Green Fluorescent ProteinsIBA
01/2021
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2021
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2020
1Tacrolimus (Prograf)FDA LinkGeneric
01/2020
1Polysaccharides (Glycans)IBA
01/2020
1InflammasomesIBA
01/2020
1PyrinIBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1Adenosine Triphosphate (ATP)IBA
01/2020
1Leucine (L-Leucine)FDA Link
01/2020
1LipopolysaccharidesIBA
01/2020
1IgG Receptors (Fc gamma RI)IBA
12/2019
1Alemtuzumab (Campath)FDA Link
12/2019
1IceIBA
01/2019
1AlbuminsIBA
01/2019
1GlycolipidsIBA
06/2017
1CytokinesIBA
06/2017
1CD1d AntigensIBA
06/2017
1AnaphylatoxinsIBA
01/2016
1Monoclonal AntibodiesIBA
11/2015
1N-Acetylneuraminic Acid (Sialic Acid)IBA
11/2015
1Immunoglobulin Fc FragmentsIBA
11/2015
1Amyloid (Amyloid Fibrils)IBA
02/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2011

Therapy/Procedure

3Therapeutics
05/2021 - 01/2017
2Immunotherapy
06/2017 - 01/2017
1Organ Transplantation
01/2020
1Plasmapheresis
01/2016